2,3-benzodiazepines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890147
SERIAL NO

14421994

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

What is described are BET protein-inhibitory, in particular BRD4-inhibitory 2,3-benzodiazepines of the general formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTGERMANY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bäurle, Stefan Berlin, DE 52 411
Busemann, Matthias Berlin, DE 5 3
Cleve, Arwed Berlin, DE 43 442
Fernandez-Montalvan, Amaury Ernesto Berlin, DE 36 116
Haendler, Bernard Berlin, DE 23 68
Holton, Simon Berlin, DE 36 83
Krause, Sabine Berlin, DE 6 22
Kuhnke, Joachim Potsdam, DE 46 199
Lejeune, Pascale Berlin, DE 19 63
Mönning, Ursula Woltersdorf, DE 42 97
Schmees, Norbert Berlin, DE 61 240
Siegel, Stephan Berlin, DE 33 153

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00